இம்யூனாலஜி வழக்கு அறிக்கைகள்

What do we know about cancer immunotherapy? Long-term survival and immune-related adverse events

• D errico G, Miranda J, Ostios L, Villamayor J

Esquisse of the epidemiological scenario of chagas disease in Brazil.

• Brasileiro MR

Human visceral leishmaniosis: Epidemiological analysis of the Brazilian territory.

• Brasileiro MR

Harnessing the Immune Regulatory Balance of Toll-like Receptor 9 Agonists in Cancer Immunotherapy.

• Cui J, Bai L, Zhou L, Chen W, Chen J